These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25586810)

  • 1. Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial.
    Stoddart A; van der Pol M; Pinnock H; Hanley J; McCloughan L; Todd A; Krishan A; McKinstry B
    J Telemed Telecare; 2015 Mar; 21(2):108-18. PubMed ID: 25586810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish 'TeleCare North' cluster-randomised trial.
    Witt Udsen F; Lilholt PH; Hejlesen O; Ehlers L
    BMJ Open; 2017 May; 7(5):e014616. PubMed ID: 28515193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised clinical trial of the effectiveness of home-based health care with telemonitoring in patients with COPD.
    McDowell JE; McClean S; FitzGibbon F; Tate S
    J Telemed Telecare; 2015 Mar; 21(2):80-7. PubMed ID: 25586812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.
    Hofer F; Achelrod D; Stargardt T
    Appl Health Econ Health Policy; 2016 Dec; 14(6):691-701. PubMed ID: 27475635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
    Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
    BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure: the TEHAF-study.
    Boyne JJ; Van Asselt AD; Gorgels AP; Steuten LM; De Weerd G; Kragten J; Vrijhoef HJ
    J Telemed Telecare; 2013 Jul; 19(5):242-8. PubMed ID: 24163233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: An Economic Evaluation Alongside a Randomised Controlled Trial.
    Burns DK; Wilson EC; Browne P; Olive S; Clark A; Galey P; Dix E; Woodhouse H; Robinson S; Wilson A
    Appl Health Econ Health Policy; 2016 Feb; 14(1):105-15. PubMed ID: 26346590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis.
    Kaambwa B; Bryan S; Jowett S; Mant J; Bray EP; Hobbs FD; Holder R; Jones MI; Little P; Williams B; McManus RJ
    Eur J Prev Cardiol; 2014 Dec; 21(12):1517-30. PubMed ID: 23990660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.
    Jiang X; Yao J; You JH
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17846. PubMed ID: 32407288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program.
    Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home telemonitoring effectiveness in COPD: a systematic review.
    Cruz J; Brooks D; Marques A
    Int J Clin Pract; 2014 Mar; 68(3):369-78. PubMed ID: 24472009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial.
    Boland MR; Kruis AL; Tsiachristas A; Assendelft WJ; Gussekloo J; Blom CM; Chavannes NH; Rutten-van Mölken MP
    BMJ Open; 2015 Nov; 5(10):e007284. PubMed ID: 26525419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial.
    Walker PP; Pompilio PP; Zanaboni P; Bergmo TS; Prikk K; Malinovschi A; Montserrat JM; Middlemass J; Šonc S; Munaro G; Marušič D; Sepper R; Rosso R; Siriwardena AN; Janson C; Farré R; Calverley PMA; Dellaca' RL
    Am J Respir Crit Care Med; 2018 Sep; 198(5):620-628. PubMed ID: 29557669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of physical activity in the management of COPD patients in the UK.
    Ramos M; Lamotte M; Gerlier L; Svangren P; Miquel-Cases A; Haughney J
    Int J Chron Obstruct Pulmon Dis; 2019; 14():227-239. PubMed ID: 30697043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada.
    Padwal RS; So H; Wood PW; Mcalister FA; Siddiqui M; Norris CM; Jeerakathil T; Stone J; Valaire S; Mann B; Boulanger P; Klarenbach SW
    J Clin Hypertens (Greenwich); 2019 Feb; 21(2):159-168. PubMed ID: 30570200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-utility analysis of telemonitoring versus conventional hospital-based follow-up of patients with pacemakers. The NORDLAND randomized clinical trial.
    Lopez-Villegas A; Catalan-Matamoros D; Peiro S; Lappegard KT; Lopez-Liria R
    PLoS One; 2020; 15(1):e0226188. PubMed ID: 31995558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a Telemonitoring Program for Patients With Heart Failure During the COVID-19 Pandemic in Hong Kong: Model Development and Data Analysis.
    Jiang X; Yao J; You JH
    J Med Internet Res; 2021 Mar; 23(3):e26516. PubMed ID: 33656440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.
    Spencer M; Briggs AH; Grossman RF; Rance L
    Pharmacoeconomics; 2005; 23(6):619-37. PubMed ID: 15960557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telemonitoring and home hospitalization in patients with chronic obstructive pulmonary disease: study TELEPOC.
    Mirón Rubio M; Ceballos Fernández R; Parras Pastor I; Palomo Iloro A; Fernández Félix BM; Medina Miralles J; Zamudio López E; González Pastor J; Amador Lorente C; Mena Hortelano N; Domínguez Sánchez A; Alonso-Viteri S
    Expert Rev Respir Med; 2018 Apr; 12(4):335-343. PubMed ID: 29460648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium.
    Hettle R; Wouters H; Ayres J; Gani R; Kelly S; Lion M; Decramer M
    Respir Med; 2012 Dec; 106(12):1722-33. PubMed ID: 23040833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.